StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC)
Equities research analysts at StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock. GlycoMimetics Stock Performance Shares of NASDAQ:GLYC opened at $0.28 on Monday. The firm has a 50 day […]
Equities research analysts at StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock. GlycoMimetics Stock Performance Shares of NASDAQ:GLYC opened at $0.28 on Monday. The firm has a 50 day […]
